Long-Term Effectiveness of Elvanse in Children with ADHD
Research question: What is the long-term effectiveness and safety profile of Elvanse for treating ADHD in children?
Plain-language summary
Research suggests that Elvanse (lisdexamfetamine dimesylate) is generally effective and well-tolerated for treating ADHD in children over the long term. However, like all medications, it can have side effects, and individual responses to treatment can vary. More extensive studies specifically focusing on very long-term safety beyond a few years are still beneficial to understand its full profile.
Key findings
- Elvanse is considered an effective treatment for ADHD symptoms in children, helping with things like attention and hyperactivity.
- The medication generally has a favorable safety profile, meaning serious side effects are uncommon.
- Common side effects can include appetite suppression, insomnia, and weight loss, though these are often manageable.
- The benefits of Elvanse in managing ADHD symptoms appear to be sustained over longer periods of treatment.
- It's important for a doctor to monitor children on Elvanse to manage any potential side effects and ensure the treatment remains appropriate.
Studies cited (1)
- Lisdexamfetamine Dimesylate: A Review in Paediatric ADHD — Frampton JE (2018, Drugs, review)
DOI: 10.1007/s40265-018-0936-0
Based on 1 curated peer-reviewed studies (from 1 matches across PubMed, Semantic Scholar, and Europe PMC).